Biopharmaceutical industry and healthcare are being transformed by a variety of novel technolgies coming into research and business practises. From artificial intelligence and big data tools, to quantum computing, next generation proteomics, and virtual reality -- novel technologies are disrupting the traditional research and business models, and helping innovate at a greater scale, faster, and cheaper.
Feb. 15, 2018
by Peter Jarowski
Biopharma insight
In the domain of drug discovery, there can be a world of difference between a computer-generated hit compound, which is …
Jan. 18, 2018
by Andrii Buvailo
Interview
The previous year was rich in discussions and events one way or another related to potential applications of artificial intelligence …
Jan. 11, 2018
by Andrii Buvailo
Biopharma insight
With all the hot discussions (for instance, here, here, here and here) going on right now among medicinal chemists, pharmaceutical …
Jan. 2, 2018
by Alfred Ajami
Biopharma insight
Effective drug discovery begins with the right assay, but the definition of "right" will shift as technology advances. More often …
Dec. 26, 2017
by Andrii Buvailo
Interview
Without a doubt, the area of artificial intelligence (AI) has been a sensation lately -- judging by the amount of …
Nov. 22, 2017
by Alfred Ajami, Andrii Buvailo
Biopharma insight
Choosing the right biological target or a combination of targets is a fundamental task for any successful drug discovery project. …
Nov. 22, 2017
by Alfred Ajami
Biopharma insight
The question is often raised, but the answer remains to be uncovered because the definition of drug "target" continues to …
Nov. 14, 2017
by Andrii Buvailo
Biopharma insight
In this interview, Dr. Jackie Hunter, CEO at BenevolentAI, provides insights into how the company’s AI-driven platform helps scientists create …
Sept. 24, 2017
by Andrii Buvailo
Biopharma insight
Boston-based LifeMine Therapeutics, a fresh new drug discovery startup, just announced a $55 million Series A financing from a number …
Aug. 21, 2017
by BiopharmaTrend
Biopharma insight
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from …
Aug. 18, 2017
by BiopharmaTrend
Biopharma insight
IBM developed machine learning models to analyze correlations between diseases and side effects commonly caused by the medications used to …
Dec. 3, 2016
by Andrii Buvailo
Biopharma insight
An IBM’s executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is …